There are pros and cons for weight loss medications like Ozempic
"Ozempic face." Five years ago, if you'd heard those words you would probably think it referred to an alien species.
Aug 29, 2025
0
23
Amino Acids, Peptides, and Proteins: News and Research on Glucagon-Like Peptide-1 Receptor
MeSH tree: D12.776.543.750.695.021.500
Imaging approach illuminates how weight loss drugs target the brain and pancreas
An international research team from Leibniz-FMP, the University of Oxford, and the University of Birmingham have developed a novel imaging approach to track how popular dual agonist drugs like tirzepatide interact with cells ...
Aug 20, 2025
0
29
Experts recommend SGLT-2 and GLP-1 only for adults at moderate to high risk of heart and kidney problems
SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher risk of cardiovascular and kidney complications, and in the majority of adults at moderate risk of ...
Aug 14, 2025
0
31
Pharmacotherapy for the management of obesity—an updated guideline
Pharmacotherapy is an effective, evidence-based treatment for people living with obesity, as part of a long-term, individualized treatment plan. An updated pharmacotherapy guideline for obesity management in adults reflects ...
Aug 11, 2025
0
37
Anti-obesity medications associated with weight rebound post-treatment
Patients prescribed drugs to help them lose weight may experience a rebound in weight gain after halting their prescription, finds a meta-analysis published in BMC Medicine.
Jul 21, 2025
0
51
What are drugs like Ozempic doing to the brains of people that binge eat?
Medications like Ozempic are not going anywhere anytime soon.
Jul 20, 2025
0
38
Survey shows GLP-1 weight-loss drugs are changing sex and dating for 50–60% of users
GLP-1 weight-loss drugs are changing how people date and connect. In a nationally representative survey of 2,000 single U.S. adults (ages 18 to 91) led by the Kinsey Institute at Indiana University with DatingAdvice.com, ...
Jul 16, 2025
0
23
Study finds patients with interrupted GLP-1 access still achieve significant weight loss
Popular anti-obesity medications continue to be effective for weight loss even when availability and access is interrupted, according to a study being presented by a private weight-loss company Monday at ENDO 2025, the Endocrine ...
Jul 14, 2025
0
14
Combination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss
Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with overweight or obesity compared to use of tirzepatide treatment alone, according to a study being ...
Jul 12, 2025
0
27
Mouse study finds tirzepatide slowed obesity-associated breast cancer growth
The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a study being presented Saturday at ENDO ...
Jul 12, 2025
0
35
